|Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology|
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
|Cannabidiol for the treatment of psychosis in Parkinson’s disease|
AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ...
Journal of Psychopharmacology 23 (8), 979-983, 2009
|Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco–magnetic resonance imaging study|
JFW Deakin, J Lees, S McKie, JEC Hallak, SR Williams, SM Dursun
Archives of general psychiatry 65 (2), 154-164, 2008
|Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment|
IB Chaudhry, J Hallak, N Husain, F Minhas, J Stirling, P Richardson, ...
Journal of psychopharmacology 26 (9), 1185-1193, 2012
|Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.|
K Black, C Shea, S Dursun, S Kutcher
Journal of Psychiatry and Neuroscience 25 (3), 255, 2000
|Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions|
L Urichuk, TI Prior, S Dursun, G Baker
Current drug metabolism 9 (5), 410-418, 2008
|Cannabidiol monotherapy for treatment-resistant schizophrenia|
AW Zuardi, JEC Hallak, SM Dursun, SL Morais, RF Sanches, RE Musty, ...
Journal of Psychopharmacology 20 (5), 683-686, 2006
|Neurological complications of psychiatric drugs: clinical features and management|
PM Haddad, SM Dursun
Human Psychopharmacology: Clinical and Experimental 23 (S1), S15-S26, 2008
|An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria|
JW Radomski, SM Dursun, MA Reveley, SP Kutcher
Medical hypotheses 55 (3), 218-224, 2000
|Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis|
L Hartling, AM Abou-Setta, S Dursun, SS Mousavi, D Pasichnyk, ...
Annals of internal medicine 157 (7), 498-511, 2012
|Cholesterol and mental disorder|
PF Boston, SM Dursun, MA Reveley
The British Journal of Psychiatry 169 (6), 682-689, 1996
|ADHD-200 Global Competition: diagnosing ADHD using personal characteristic data can outperform resting state fMRI measurements|
MRG Brown, GS Sidhu, R Greiner, N Asgarian, M Bastani, PH Silverstone, ...
Frontiers in systems neuroscience 6, 69, 2012
|An overview of animal models related to schizophrenia|
IR Winship, SM Dursun, GB Baker, PA Balista, L Kandratavicius, ...
The Canadian Journal of Psychiatry 64 (1), 5-17, 2019
|Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic caseseries outcome study|
SM Dursun, JFW Deakin
Journal of Psychopharmacology 15 (4), 297-301, 2001
|Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness|
J Hamill, J Hallak, SM Dursun, G Baker
Current neuropharmacology 17 (2), 108-128, 2019
|Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial|
JEC Hallak, JP Maia-de-Oliveira, J Abrao, PR Evora, AW Zuardi, ...
JAMA psychiatry 70 (7), 668-676, 2013
|Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation|
A Briggs, D Wild, M Lees, M Reaney, S Dursun, D Parry, J Mukherjee
Health and quality of life outcomes 6 (1), 1-9, 2008
|Clozapine plus lamotrigine in treatment-resistant schizophrenia|
SM Dursun, D McIntosh, H Milliken
Archives of general psychiatry 56 (10), 950-950, 1999
|Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers|
D Matveychuk, RK Thomas, J Swainson, A Khullar, MA MacKay, ...
Therapeutic advances in psychopharmacology 10, 2045125320916657, 2020
|Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorder|
L Riske, RK Thomas, GB Baker, SM Dursun
Therapeutic advances in psychopharmacology 7 (2), 85-89, 2017